Concepedia

Abby Marquez

AM

Statistics

Publications

13

Citations

1.6K

H-Index

13

Active since

2018

Affiliations

Revolution Medicines (United States)(Current)

Memorial Sloan Kettering Cancer Center

Broad Institute

Harvard University

Dana-Farber Cancer Institute

Abby Marquez is an author at Revolution Medicines (United States) specializing in molecular oncology, medicine, and oncology.

Publications per year

2018–2025

13

Publications

13

RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1- and RAS-driven cancers

Robert J. Nichols, Franziska Haderk, Carlos Stahlhut et al. · Nature Cell Biology · 2018 · 418 citations

Medicine, Molecular Biology, Oncology +16

Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy

Matthew Holderfield, Bianca J. Lee, Jingjing Jiang et al. · Nature · 2024 · 318 citations · Full text

Medicine, Oncology, Pharmacology +16

Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers

Jingjing Jiang, Lingyan Jiang, Benjamin J. Maldonato et al. · Cancer Discovery · 2024 · 281 citations · Full text

Medicine, Oncology, Pharmacology +17

Chemical remodeling of a cellular chaperone to target the active state of mutant KRAS

Christopher J. Schulze, Kyle J. Seamon, Yulei Zhao et al. · Science · 2023 · 232 citations · Full text

Medicine, Medicinal Chemistry, Oncology +17

Selective inhibitors of mTORC1 activate 4EBP1 and suppress tumor growth

Bianca J. Lee, Jacob A. Boyer, G. Leslie Burnett et al. · Nature Chemical Biology · 2021 · 82 citations · Full text

Medicine, Oncology, Pharmacology +14

1–5 of 13